Hypothesis: is accumulation of a furan dicarboxylic acid (3-carboxy-4- methyl-5-propyl-2-furanpropanoic acid) related to the neurological abnormalities in patients with renal failure?
The Plasma concentrations of a lipophilic furan dicarboxylic acid (3- carboxy-4-methyl-5-propyl-2-fluranpropanoic acid; 5-propyl FPA), which is highly bound to albumin and not removed by haemodialysis, have been measured in patients with renal impairment who were not dialysis dependent or who were t...
Автори: | Costigan, MG, Callaghan, C, Lindup, W |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
1996
|
Схожі ресурси
Схожі ресурси
-
Relationship of plasma 3‐carboxy‐4‐methyl‐5‐propyl‐2‐furanpropanoic acid concentration with OATP1B activity in patients with chronic kidney disease
за авторством: Hiroyuki Ono, та інші
Опубліковано: (2024-02-01) -
Circulating 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) levels are associated with hyperglycemia and β cell dysfunction in a Chinese population
за авторством: Shan Zhang, та інші
Опубліковано: (2017-06-01) -
3-Carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF) induces cell death through ferroptosis and acts as a trigger of apoptosis in kidney cells
за авторством: Jung Sun Park, та інші
Опубліковано: (2023-02-01) -
Direct synthesis of furan-2,5-dicarboxylic acid monoamides
за авторством: Róbert Fischer, та інші
Опубліковано: (2015-09-01) -
Process Analysis of Furan Dicarboxylic Acid Production from Lignocellulose Biomass
за авторством: Dang Saebea, та інші
Опубліковано: (2024-07-01)